More recently, we demonstrated that the risk of relapse could be distinguished based on the response of their CTC to adjuvant chemotherapy [17] and we reviewed our experience regarding the prognostic role of CK-19 positive CTC in operable breast cancer [22]. Here, KRT19 is linked to breast cancer.